Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.80
+0.41 (7.61%)
At close: Nov 28, 2025, 1:00 PM EST
5.99
+0.19 (3.28%)
After-hours: Nov 28, 2025, 4:49 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $1.03 billion as of November 28, 2025. Its market cap has increased by 318.87% in one year.
Market Cap
1.03B
Enterprise Value
821.57M
1-Year Change
318.87%
Ranking
Category
Stock Price
$5.80
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $1.03B, an increase of 136.97%. That is a compound annual growth rate of 20.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.03B | 417.08% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |